Clinical Trials Logo

Thyroid Cancer, Anaplastic clinical trials

View clinical trials related to Thyroid Cancer, Anaplastic.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03565536 Completed - Clinical trials for Thyroid Cancer, Anaplastic

Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer

Start date: May 1, 2018
Phase: Phase 2
Study type: Interventional

Undifferentiated thyroid cancer is the most malignant tumor of the thyroid gland, with a median survival of only 3 months. Most undifferentiated cancers lose the chance of surgery when they are first diagnosed. The current study, Nexavar, is used only for dedifferentiated thyroid cancer and has not been applied to undifferentiated cancer. This study attempted to apply it to preoperative treatment of undifferentiated cancer to see if it would shrink the tumor and give the patient an opportunity for surgery.